Condition: Myeloproliferative Neoplasm · Polycythemia Vera · Essential Thrombocythemia · Sponsor: The University of Hong Kong
This is a multinational, multicenter, prospective and retrospective, observational, cohort study of patients with myeloproliferative neoplasm.
This description comes directly from the study's public registry record.
Harinder Gill, MD · +852 22554542 · gillhsh@hku.hk
Always discuss trial participation with your own doctor first.
| Department of Medicine, Queen Mary Hospital | Hong Kong, Hong Kong | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05882773